• Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: Findings and future implications 

      Godman, Brian; Wettermark, Björn; van Woerkom, Menno; Fraeyman, Jessica; Alvarez-Madrazo, Samantha; Berg, Christian Lie; Bishop, Iain; Bucsics, Anna; Campbell, Stephen; Finlayson, Alexander E.; Fürst, Jurij; Garuoliene, Kristina; Herholz, Harald; Kalaba, Marija; Laius, Ott; Piessnegger, Jutta; Sermet, Catherine; Schwabe, Ulrich; Vlahovic-Palcevski, Vera V.; Markovic-Pekovic, Vanda; Vončina, Luka; Malinowska, Kamila; Zara, Corinne; Gustafsson, Lars L. (Journal article, 2014)
    • The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures 

      Moorkens, Evelien; Godman, Brian; Huys, Isabelle; Hoxha, Iris; Malaj, Admir; Keuerleber, Simon; Stockinger, Silvia; Mörtenhuber, Sarah; Dimitrova, Maria; Tachkov, Konstantin; Vončina, Luka; Palčevski, Vera Vlahović; Achniotou, Gnosia; Slabý, Juraj; Popelková, Leona; Kohoutová, Kateřina; Bartels, Dorthe; Laius, Ott; Martikainen, Jaana E.; Selke, Gisbert; Kourafalos, Vasileios; Magnusson, Einar; Einarsdóttir, Rannveig; Adams, Roisín; Joppi, Roberta; Allocati, Eleonora; Jakupi, Arianit; Viksna, Anita; Greičiūtė-Kuprijanov, Ieva; Vella Bonanno, Patricia; Suttorp, Vincent; Melien, Øyvind; Plisko, Robert; Mardare, Ileana; Meshkov, Dmitry; Novakovic, Tanja; Fürst, Jurij; Zara, Corrine; Markovic-Pekovic, Vanda; Grubiša, Nataša; Befrits, Gustaf; Puckett, Robert; Vulto, Arnold G. (Peer reviewed; Journal article, 2021)